MFDS — authorised 12 August 2013
- Marketing authorisation holder: VIIV HLTHCARE
- Status: likely_approved
🇰🇷 Tivicay in South Korea
MFDS authorised Tivicay on 12 August 2013
Marketing authorisation
Tivicay in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Tivicay approved in South Korea?
Yes. MFDS authorised it on 12 August 2013.
Who is the marketing authorisation holder for Tivicay in South Korea?
VIIV HLTHCARE holds the South Korean marketing authorisation.